NFE2L2 and epilepsy: The administration of dimethyl fumarate, an activator of the Nrf2 pathway, significantly reduced seizures, suppressed pro-inflammatory cytokines, and enhanced the gene expression of Nrf2, NQO1, and HO-1 in the chemical kindling epilepsy rat model [227].